期刊文献+

益气养阴补肾方联合阿卡波糖对老年糖尿病临床效果分析

Clinical Effect Analysis of Yiqi Yangyin Bushen Recipe Combined with Acarbose on Senile Diabetes
下载PDF
导出
摘要 目的探究对老年糖尿病患者运用益气养阴补肾方与阿卡波糖联合治疗的临床价值。方法选取于2017年12月-2019年5月该院收治的老年糖尿病患者98例,随机分为观察组(益气养阴补肾方与阿卡波糖联合治疗)和对照组(单纯阿卡波糖治疗)各49例。结果与对照组相比,观察组治疗总有效率(91.84%)较高(χ^2=15.895,P<0.05),治疗后,观察组糖化血红蛋白、餐后2 h血糖和空腹血糖水平改善更明显(t=11.655、11.284、10.528,P<0.05),且两组不良反应发生率差异无统计学意义(χ^2=0.924,P>0.05)。结论对老年糖尿病患者运用益气养阴补肾方与阿卡波糖联合治疗后,在提高治疗效果,改善患者血糖水平的同时,还存在较低的不良反应发生率,其具有显著的临床价值。 Objective To explore the clinical value of Yiqi Yangyin Bushen Recipe combined with acarbose for elderly diabetic patients.Methods A total of 98 elderly diabetic patients treated in the hospital from December 2017 to May 2019 were randomly divided into the observation group(Yiqi Yangyin Bushen Recipe and Acarbose combined treatment)and the control group(Acarbose alone treatment)49 cases each.Results Compared with the control group,the total effective rate of treatment in the observation group(91.84%)was higher(χ^2=15.895,P<0.05).After treatment,the levels of glycated hemoglobin,2-hour postprandial blood glucose,and fasting blood glucose in the observation group improved more significantly(t=11.655,11.284,10.528,P<0.05),and the incidence of adverse reactions in the two groups was not statistically significant difference(χ^2=0.924,P>0.05).Conclusion The combination of Yiqi Yangyin Bushen Recipe and acarbose for elderly diabetic patients can improve the treatment effect and improve the blood glucose level of patients,but also has a low incidence of adverse reactions,which has significant clinical value.
作者 戴美芝 DAI Mei-zhi(Department of Pharmacy,Kanzhuang Town Health Center,Zoucheng,Jining,Shandong Province,273502 China)
出处 《糖尿病新世界》 2020年第9期68-69,72,共3页 Diabetes New World Magazine
关键词 益气养阴补肾方 阿卡波糖 老年糖尿病 Yiqi Yangyin Bushen Recipe Acarbose Aged diabetes
  • 相关文献

参考文献11

二级参考文献69

  • 1王群让.血栓通注射液治疗2型糖尿病临床观察[J].中国煤炭工业医学杂志,2006,9(3):272-273. 被引量:2
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2096
  • 3郑莜萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002.286.
  • 4葛均波,徐永建.内科学[M].8版.2014:738-739.
  • 5hoh Y, Nakai A, KakizawaH,et al. Alteration of endothelin- lconcentra tion in STZ - induced diabetic rat nephropathy. Ef - fects of a PGI2 derivative [ J ]. Hormone Research,2001,56 (5 - 6) : 165 - 171.
  • 6Tuttle KR. Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease [ J ]. J Am Soc Neprol, 2005,16 ( 6 ) : 1537 - 1538.
  • 7Paul SK,Maggs D,Klein K, et al. Dynamic risk factors assoei ated with non severe hypoglycemia in patients treated with insu- lin glargine or exenatide once weekly. J Diabetes, 2015,7 : 60 67.
  • 8Bloomgarden Z, Handelsman Y. Lessons from glargine trials: What is the goal fasting glucose with basal insulin.9 . J Diabe tes, 2014,6 : 271-273.
  • 9胡元会.冠心病心绞痛中医诊疗方案(初稿)[J].中华中医药杂志,2008,23(9):806-810. 被引量:43
  • 10金昕晔,邹大进.米格列奈治疗2型糖尿病的相关研究介绍[J].中国糖尿病杂志,2008,16(11):699-700. 被引量:7

共引文献211

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部